Chenghao Wang

843 total citations
34 papers, 599 citations indexed

About

Chenghao Wang is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chenghao Wang has authored 34 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 12 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chenghao Wang's work include Esophageal Cancer Research and Treatment (9 papers), Gastric Cancer Management and Outcomes (8 papers) and Esophageal and GI Pathology (7 papers). Chenghao Wang is often cited by papers focused on Esophageal Cancer Research and Treatment (9 papers), Gastric Cancer Management and Outcomes (8 papers) and Esophageal and GI Pathology (7 papers). Chenghao Wang collaborates with scholars based in China, Canada and Ethiopia. Chenghao Wang's co-authors include Zhao–You Tang, De-Ning Ma, Chengdong Qin, Xiao‐Dong Zhu, Hui‐Chuan Sun, Dongmei Gao, Manqing Cao, Hao Cai, Wen-Kai Shi and Bo‐Gen Ye and has published in prestigious journals such as Scientific Reports, Pain and Neuroscience.

In The Last Decade

Chenghao Wang

30 papers receiving 594 citations

Peers

Chenghao Wang
Qikai Sun China
Limin Zhai China
Ji-Hai Yu China
Benjamin L. Emmink Netherlands
Wenbin Huang China
Mei-Yin Zhang China
Guohe Song China
Jennifer Hanson Canada
Xianqiu Wu China
Qikai Sun China
Chenghao Wang
Citations per year, relative to Chenghao Wang Chenghao Wang (= 1×) peers Qikai Sun

Countries citing papers authored by Chenghao Wang

Since Specialization
Citations

This map shows the geographic impact of Chenghao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenghao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenghao Wang more than expected).

Fields of papers citing papers by Chenghao Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenghao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenghao Wang. The network helps show where Chenghao Wang may publish in the future.

Co-authorship network of co-authors of Chenghao Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Chenghao Wang. A scholar is included among the top collaborators of Chenghao Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenghao Wang. Chenghao Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
He, Wenwu, Chunyan Luo, Yan Xia, et al.. (2024). Longitudinal patient-reported outcomes after minimally invasive McKeown esophagectomy for patients with esophageal squamous cell carcinoma. Supportive Care in Cancer. 32(4). 237–237. 3 indexed citations
4.
5.
6.
Wang, Kaiyu, Bo Peng, Xiaoyan Chang, et al.. (2024). Comprehensive analysis of PPP4C’s impact on prognosis, immune microenvironment, and immunotherapy response in lung adenocarcinoma using single-cell sequencing and multi-omics. Frontiers in Immunology. 15. 1416632–1416632. 1 indexed citations
7.
Li, Kexun, Wenwu He, Kun Liu, et al.. (2024). Impact of Metastatic Lymph Nodes on Survival of Patients with pN1-Category Esophageal Squamous Cell Carcinoma: A Long-Term Survival Analysis. Annals of Surgical Oncology. 31(6). 3794–3802. 6 indexed citations
8.
9.
Li, Kexun, Wenwu He, Kun Liu, et al.. (2024). Long-term outcomes of smoker and drinker with oesophageal squamous cell carcinoma after oesophagectomy: a large-scale propensity score matching analysis. BMJ Open Gastroenterology. 11(1). e001452–e001452. 5 indexed citations
10.
Yang, Jieping, Beibei Liu, Wenxin Yan, et al.. (2024). Discovery of highly potent PARP7 inhibitors for cancer immunotherapy. Bioorganic Chemistry. 148. 107469–107469. 2 indexed citations
11.
Li, Kexun, Wenwu He, Kun Liu, et al.. (2024). Surgical vs nonsurgical treatment for esophageal squamous cell carcinoma in patients older than 70 years: a propensity score matching analysis. Journal of Gastrointestinal Surgery. 28(5). 611–620. 6 indexed citations
12.
Wang, Chenghao, et al.. (2023). IL-33/ST2 Signaling in the Pathogenesis of Chronic Pain and Itch. Neuroscience. 529. 16–22. 11 indexed citations
13.
Chen, Yuepeng, Wenze Wang, Ye Liu, et al.. (2023). Design, synthesis and biological evaluation of novel DCLK1 inhibitor containing purine skeleton for the treatment of pancreatic cancer. European Journal of Medicinal Chemistry. 261. 115846–115846. 6 indexed citations
14.
Lu, Tong, Ran Xu, Chenghao Wang, et al.. (2022). Identification of Tumor Antigens and Immune Subtypes of Esophageal Squamous Cell Carcinoma for mRNA Vaccine Development. Frontiers in Genetics. 13. 853113–853113. 6 indexed citations
15.
16.
Cao, Manqing, A‐Bin You, Xiao‐Dong Zhu, et al.. (2018). miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a. Journal of Hematology & Oncology. 11(1). 12–12. 177 indexed citations
17.
Qin, Chengdong, De-Ning Ma, Shi-Zhe Zhang, et al.. (2018). The Rho GTPase Rnd1 inhibits epithelial–mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target. Cell Death and Disease. 9(5). 486–486. 21 indexed citations
18.
19.
Qin, Chengdong, De-Ning Ma, Zhenggang Ren, et al.. (2017). Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway. Oncology Reports. 37(3). 1725–1735. 43 indexed citations
20.
Ma, De-Ning, Zong‐Tao Chai, Xiao‐Dong Zhu, et al.. (2016). MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2. Journal of Hematology & Oncology. 9(1). 1–1. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qikai Sun Breakdown of academic impact, for papers by Limin Zhai Breakdown of academic impact, for papers by Ji-Hai Yu Breakdown of academic impact, for papers by Benjamin L. Emmink Breakdown of academic impact, for papers by Wenbin Huang Breakdown of academic impact, for papers by Mei-Yin Zhang Breakdown of academic impact, for papers by Guohe Song Breakdown of academic impact, for papers by Jennifer Hanson Breakdown of academic impact, for papers by Xianqiu Wu
Rankless by CCL
2026